UroGen Pharma (URGN) PT Lowered to $34 at Oppenheimer
Tweet
Share
E-mailGet Alerts URGN Hot Sheet
Price: $44.88 --0%
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 2
Rating Summary:
10 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 7 | New: 2
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell lowered the price target on UroGen Pharma (NASDAQ: URGN) to $34.00 (from $40.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zscaler (ZS) PT Raised to $225 at Stephens
- Keyera Corp. (KEY:CN) (KEYUF) PT Lowered to Cdn$64 at BMO Capital
- BRP Inc. (DOO:CN) (DOOO) PT Raised to Cdn$110 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
